{"id":82952,"date":"2025-04-12T14:56:16","date_gmt":"2025-04-12T09:26:16","guid":{"rendered":"https:\/\/vanillanews.com\/index.php\/2025\/04\/12\/dr-reddys-collaborates-with-chinas-bio-thera-in-new-agreement-expanding-pharmaceutical-reach\/"},"modified":"2025-04-12T14:56:16","modified_gmt":"2025-04-12T09:26:16","slug":"dr-reddys-collaborates-with-chinas-bio-thera-in-new-agreement-expanding-pharmaceutical-reach","status":"publish","type":"post","link":"https:\/\/vanillanews.com\/index.php\/2025\/04\/12\/dr-reddys-collaborates-with-chinas-bio-thera-in-new-agreement-expanding-pharmaceutical-reach\/","title":{"rendered":"Dr. Reddy&#8217;s collaborates with China&#8217;s Bio-Thera in new agreement, expanding pharmaceutical reach."},"content":{"rendered":"<p>In a significant development in the pharmaceutical industry, Dr. Reddy&#8217;s Laboratories has signed a strategic collaboration agreement with China&#8217;s Bio-Thera Solutions. This partnership aims to bring innovative therapies to patients in India. The agreement includes an exclusive license and supply agreement for Bio-Thera&#8217;s BAT2506, a proposed biosimilar to bevacizumab. Dr. Reddy&#8217;s will have the commercialization rights for the product in India. Bevacizumab is used to treat various types of cancer and is a widely prescribed medication globally. This collaboration underscores Dr. Reddy&#8217;s commitment to expanding its biosimilars portfolio and making high-quality healthcare more accessible to patients. The partnership with Bio-Thera, a leading biotechnology company in China, is expected to enhance Dr. Reddy&#8217;s position in the Indian pharmaceutical market. With the increasing demand for biosimilars in India, this collaboration is poised to address the unmet medical needs of patients. Dr. Reddy&#8217;s has been at the forefront of developing and commercializing biosimilar products, and this agreement further strengthens its position in the industry. This strategic collaboration is a significant step towards providing affordable and innovative treatment options to patients in India. As the pharmaceutical sector continues to evolve, partnerships like this will play a crucial role in driving growth and innovation in the industry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a significant development in the pharmaceutical industry, Dr. Reddy&#8217;s Laboratories has signed a strategic collaboration agreement with China&#8217;s Bio-Thera Solutions. This partnership aims to bring innovative therapies to patients in India. The agreement includes an exclusive license and supply agreement for Bio-Thera&#8217;s BAT2506, a proposed biosimilar to bevacizumab. Dr. Reddy&#8217;s will have the commercialization [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":82953,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[25],"tags":[],"aioseo_notices":[],"featured_image_urls":{"full":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-119554525imgsize-46826.jpg",800,589,false],"thumbnail":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-119554525imgsize-46826-150x150.jpg",150,150,true],"medium":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-119554525imgsize-46826-300x221.jpg",300,221,true],"medium_large":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-119554525imgsize-46826-768x565.jpg",640,471,true],"large":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-119554525imgsize-46826.jpg",640,471,false],"1536x1536":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-119554525imgsize-46826.jpg",800,589,false],"2048x2048":["https:\/\/vanillanews.com\/wp-content\/uploads\/2025\/04\/msid-119554525imgsize-46826.jpg",800,589,false]},"author_info":{"display_name":"","author_link":"https:\/\/vanillanews.com\/index.php\/author\/"},"category_info":"<a href=\"https:\/\/vanillanews.com\/index.php\/category\/just-in\/\" rel=\"category tag\">JUST IN<\/a>","tag_info":"JUST IN","comment_count":"0","_links":{"self":[{"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/posts\/82952"}],"collection":[{"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/comments?post=82952"}],"version-history":[{"count":0,"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/posts\/82952\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/media\/82953"}],"wp:attachment":[{"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/media?parent=82952"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/categories?post=82952"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vanillanews.com\/index.php\/wp-json\/wp\/v2\/tags?post=82952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}